DVA's first-quarter 2026 results benefit from expanding margins and steady dialysis demand across its broad clinic network.

Q1 2026 Management View "We delivered strong financial results ahead of our expectations with outperformance from each element of our U.S. dialysis trilogy; treatment volume, revenue per treatment and ...

DaVita (NYSE:DVA) reported first-quarter 2026 results that came in ahead of internal expectations, supported by balanced ...

Shares of DaVita (DVA) added ~20% to reach an all-time high on Wednesday after the dialysis services provider reported better ...

Integrated Kidney Care (IKC): DaVita’s coordinated, value-based care program for kidney disease management, integrating ...

(Reuters) -DaVita said on Monday it was hit by a ransomware attack that encrypted certain elements of its network, and some of its operations remained disrupted despite interim measures. While the ...

Kidney care giant DaVita has acquired transplant software company MedSleuth to ease access burdens on kidney and liver transplant candidates. MedSleuth’s products won’t be used by DaVita’s providers ...

In 1999, a company called Total Renal Care, a kidney dialysis provider, was nearly bankrupt. In October of that year, Kent Thiry took over as CEO and started the long road back, taking a very ...

Getting your Trinity Audio player ready... News that Fortune 500 company DaVita Dialysis is moving its headquarters to Denver socked its competitors like a punch in the gut. To its rivals, the ...

Getting your Trinity Audio player ready... Denver-based kidney dialysis giant DaVita Inc. on Monday said it will pay approximately $4.42 billion to acquire HealthCare Partners, the country’s largest ...

UnitedHealth strikes a $4.9 billion deal to acquire the DaVita Medical Group unit from kidney dialysis firm DaVita in an all-cash transaction. Last month, DMG posted a $5 million operating loss in the ...

UnitedHealth Group is still working with regulators to close its acquisition of DaVita Medical Group, a $4 billion deal that has dragged on much longer than investors and observers of the health ...